Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions

Standard

Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions : Normalization Reduces Intermanufacturer Threshold Variability. / Patel, Bhavik N; Vernuccio, Federica; Meyer, Mathias; Godwin, Benjamin; Rosenberg, Michael; Rudnick, Nicholas; Harring, Scott; Nelson, Rendon; Ramirez-Giraldo, Juan Carlos; Farjat, Alfredo; Marin, Daniele.

In: AM J ROENTGENOL, Vol. 212, No. 2, 02.2019, p. 366-376.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Patel, BN, Vernuccio, F, Meyer, M, Godwin, B, Rosenberg, M, Rudnick, N, Harring, S, Nelson, R, Ramirez-Giraldo, JC, Farjat, A & Marin, D 2019, 'Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions: Normalization Reduces Intermanufacturer Threshold Variability', AM J ROENTGENOL, vol. 212, no. 2, pp. 366-376. https://doi.org/10.2214/AJR.18.20115

APA

Patel, B. N., Vernuccio, F., Meyer, M., Godwin, B., Rosenberg, M., Rudnick, N., Harring, S., Nelson, R., Ramirez-Giraldo, J. C., Farjat, A., & Marin, D. (2019). Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions: Normalization Reduces Intermanufacturer Threshold Variability. AM J ROENTGENOL, 212(2), 366-376. https://doi.org/10.2214/AJR.18.20115

Vancouver

Bibtex

@article{523ffebcc6144797891b3a08c59cdba7,
title = "Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions: Normalization Reduces Intermanufacturer Threshold Variability",
abstract = "OBJECTIVE: The purpose of this study was to determine whether a single, uniform normalized iodine threshold reduces variability and enables reliable differentiation between vascular and nonvascular renal lesions independent of the dual-energy CT (DECT) platform used.MATERIALS AND METHODS: In this retrospective, HIPAA-compliant, institutional review board-approved study, 247 patients (156 men, 91 women; mean age ± SD, 67 ± 12 years old) with 263 renal lesions (193 nonvascular, 70 vascular) underwent unenhanced single-energy and contrast-enhanced DECT scans. One hundred and six nonvascular and 38 vascular lesions were scanned on two dual-source DECT (dsDECT) scanners, and 87 nonvascular and 32 vascular lesions were scanned on two rapid-kilovoltage-switching single-source DECT (rsDECT) scanners. Optimal absolute and normalized (to aorta) lesion iodine thresholds were determined for each platform type and for the entire cohort combined.RESULTS: Mean optimal absolute discriminant thresholds were 1.3 mg I/mL (95% CI, 1.2-1.9 mg I/mL), 1.6 mg I/mL (95% CI, 0.9-1.5 mg I/mL), and 1.5 mg I/mL (95% CI, 1.4-1.7 mg I/mL) for dsDECT, rsDECT, and combined cohorts, respectively. Optimal normalized discriminant thresholds were 0.3 mg I/mL (95% CI, 0.2-0.4 mg I/mL) for both the dsDECT and rsDECT cohorts, and 0.3 mg I/mL (0.3-0.4 mg I/mL) for the combined cohort. The AUC, sensitivity, and specificity for the combined optimal normalized discriminant threshold of 0.3 mg I/mL was 0.96 (95% CI, 0.92-1.00), 0.93 (0.84-0.97), and 0.95 (0.91-0.98), respectively. Normalization resulted in decreased variability and better lesion separation (effect size, 1.77 vs 1.69, p < 0.0001).CONCLUSION: The optimal absolute discriminant threshold for evaluating renal lesions varies depending on the type of DECT platform, though this difference is not statistically significant. Variation can be reduced with a better separation of vascular and nonvascular lesions by normalizing iodine quantification to the aorta.",
keywords = "Adult, Aged, Aged, 80 and over, Diagnosis, Differential, Female, Humans, Iodine/analysis, Kidney Neoplasms/blood supply, Male, Middle Aged, Radiography, Dual-Energy Scanned Projection, Retrospective Studies, Tomography, X-Ray Computed/methods, Young Adult",
author = "Patel, {Bhavik N} and Federica Vernuccio and Mathias Meyer and Benjamin Godwin and Michael Rosenberg and Nicholas Rudnick and Scott Harring and Rendon Nelson and Ramirez-Giraldo, {Juan Carlos} and Alfredo Farjat and Daniele Marin",
year = "2019",
month = feb,
doi = "10.2214/AJR.18.20115",
language = "English",
volume = "212",
pages = "366--376",
journal = "AM J ROENTGENOL",
issn = "0361-803X",
publisher = "American Roentgen Ray Society",
number = "2",

}

RIS

TY - JOUR

T1 - Dual-Energy CT Material Density Iodine Quantification for Distinguishing Vascular From Nonvascular Renal Lesions

T2 - Normalization Reduces Intermanufacturer Threshold Variability

AU - Patel, Bhavik N

AU - Vernuccio, Federica

AU - Meyer, Mathias

AU - Godwin, Benjamin

AU - Rosenberg, Michael

AU - Rudnick, Nicholas

AU - Harring, Scott

AU - Nelson, Rendon

AU - Ramirez-Giraldo, Juan Carlos

AU - Farjat, Alfredo

AU - Marin, Daniele

PY - 2019/2

Y1 - 2019/2

N2 - OBJECTIVE: The purpose of this study was to determine whether a single, uniform normalized iodine threshold reduces variability and enables reliable differentiation between vascular and nonvascular renal lesions independent of the dual-energy CT (DECT) platform used.MATERIALS AND METHODS: In this retrospective, HIPAA-compliant, institutional review board-approved study, 247 patients (156 men, 91 women; mean age ± SD, 67 ± 12 years old) with 263 renal lesions (193 nonvascular, 70 vascular) underwent unenhanced single-energy and contrast-enhanced DECT scans. One hundred and six nonvascular and 38 vascular lesions were scanned on two dual-source DECT (dsDECT) scanners, and 87 nonvascular and 32 vascular lesions were scanned on two rapid-kilovoltage-switching single-source DECT (rsDECT) scanners. Optimal absolute and normalized (to aorta) lesion iodine thresholds were determined for each platform type and for the entire cohort combined.RESULTS: Mean optimal absolute discriminant thresholds were 1.3 mg I/mL (95% CI, 1.2-1.9 mg I/mL), 1.6 mg I/mL (95% CI, 0.9-1.5 mg I/mL), and 1.5 mg I/mL (95% CI, 1.4-1.7 mg I/mL) for dsDECT, rsDECT, and combined cohorts, respectively. Optimal normalized discriminant thresholds were 0.3 mg I/mL (95% CI, 0.2-0.4 mg I/mL) for both the dsDECT and rsDECT cohorts, and 0.3 mg I/mL (0.3-0.4 mg I/mL) for the combined cohort. The AUC, sensitivity, and specificity for the combined optimal normalized discriminant threshold of 0.3 mg I/mL was 0.96 (95% CI, 0.92-1.00), 0.93 (0.84-0.97), and 0.95 (0.91-0.98), respectively. Normalization resulted in decreased variability and better lesion separation (effect size, 1.77 vs 1.69, p < 0.0001).CONCLUSION: The optimal absolute discriminant threshold for evaluating renal lesions varies depending on the type of DECT platform, though this difference is not statistically significant. Variation can be reduced with a better separation of vascular and nonvascular lesions by normalizing iodine quantification to the aorta.

AB - OBJECTIVE: The purpose of this study was to determine whether a single, uniform normalized iodine threshold reduces variability and enables reliable differentiation between vascular and nonvascular renal lesions independent of the dual-energy CT (DECT) platform used.MATERIALS AND METHODS: In this retrospective, HIPAA-compliant, institutional review board-approved study, 247 patients (156 men, 91 women; mean age ± SD, 67 ± 12 years old) with 263 renal lesions (193 nonvascular, 70 vascular) underwent unenhanced single-energy and contrast-enhanced DECT scans. One hundred and six nonvascular and 38 vascular lesions were scanned on two dual-source DECT (dsDECT) scanners, and 87 nonvascular and 32 vascular lesions were scanned on two rapid-kilovoltage-switching single-source DECT (rsDECT) scanners. Optimal absolute and normalized (to aorta) lesion iodine thresholds were determined for each platform type and for the entire cohort combined.RESULTS: Mean optimal absolute discriminant thresholds were 1.3 mg I/mL (95% CI, 1.2-1.9 mg I/mL), 1.6 mg I/mL (95% CI, 0.9-1.5 mg I/mL), and 1.5 mg I/mL (95% CI, 1.4-1.7 mg I/mL) for dsDECT, rsDECT, and combined cohorts, respectively. Optimal normalized discriminant thresholds were 0.3 mg I/mL (95% CI, 0.2-0.4 mg I/mL) for both the dsDECT and rsDECT cohorts, and 0.3 mg I/mL (0.3-0.4 mg I/mL) for the combined cohort. The AUC, sensitivity, and specificity for the combined optimal normalized discriminant threshold of 0.3 mg I/mL was 0.96 (95% CI, 0.92-1.00), 0.93 (0.84-0.97), and 0.95 (0.91-0.98), respectively. Normalization resulted in decreased variability and better lesion separation (effect size, 1.77 vs 1.69, p < 0.0001).CONCLUSION: The optimal absolute discriminant threshold for evaluating renal lesions varies depending on the type of DECT platform, though this difference is not statistically significant. Variation can be reduced with a better separation of vascular and nonvascular lesions by normalizing iodine quantification to the aorta.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Diagnosis, Differential

KW - Female

KW - Humans

KW - Iodine/analysis

KW - Kidney Neoplasms/blood supply

KW - Male

KW - Middle Aged

KW - Radiography, Dual-Energy Scanned Projection

KW - Retrospective Studies

KW - Tomography, X-Ray Computed/methods

KW - Young Adult

U2 - 10.2214/AJR.18.20115

DO - 10.2214/AJR.18.20115

M3 - SCORING: Journal article

C2 - 30667306

VL - 212

SP - 366

EP - 376

JO - AM J ROENTGENOL

JF - AM J ROENTGENOL

SN - 0361-803X

IS - 2

ER -